Picture of Zynerba Pharmaceuticals logo

ZYNE — Zynerba Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall Cap

Brief: Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results

May 15 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
    * ZYNERBA PHARMACEUTICALS INC - $44.4 MILLION IN CASH AND
CASH
EQUIVALENTS AT MARCH 31, 2023; CASH RUNWAY TO MID-YEAR 2024
    * ZYNERBA PHARMACEUTICALS INC Q1 LOSS PER SHARE $0.21

Source text for Eikon:  ID:nGNX24LFK1 
Further company coverage:  ZYNE.O

Recent news on Zynerba Pharmaceuticals

See all news